All Photos(1)
Documents
39391
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide
≥97.0% (T)
All Photos(1)
Synonym(s):
EDC, WSC, N-Ethyl-N′-(3-dimethylaminopropyl)carbodiimide
Empirical Formula (Hill Notation):
C8H17N3
CAS Number:
Molecular Weight:
155.24
Beilstein/REAXYS Number:
507429
EC Number:
MDL number:
PubChem Substance ID:
Pricing and availability is not currently available.
Quality Level
assay
≥97.0% (T)
reaction suitability
reaction type: Coupling Reactions
application(s)
peptide synthesis: suitable
refractive index
n20/D 1.461
density
0.877 g/mL at 20 °C (lit.)
storage temp.
−20°C
SMILES string
CCN=C=NCCCN(C)C
InChI
1S/C8H17N3/c1-4-9-8-10-6-5-7-11(2)3/h4-7H2,1-3H3
InChI key
LMDZBCPBFSXMTL-UHFFFAOYSA-N
Related Categories
General description
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide is commonly used in combination with N-hydroxysuccinimide (NHS) in carbodiimide coupling reaction to activate carboxyl group for coupling with amines to form amides.
Application
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide has been used for the surface functionalization of graphene quantum dots (GQDs) employed as sensing probes in Janus micromotors to detect enterobacterial contamination. It has also been used for the activation of folic acid, prior to its conjugation on silica nanoparticles.
Packaging
50 mL in Sure/Seal™
10 mL in glass bottle
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. 39391.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Signal Word
Danger
Hazard Statements
Precautionary Statements
Personal Protective Equipment
RIDADR
UN 2735PSN1 8 / PGIII
WGK Germany
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificate of Analysis
Certificate of Origin
More documents
Hui Liu et al.
Colloids and surfaces. B, Biointerfaces, 181, 143-148 (2019-05-28)
CTC detection has great potential to provide crucial clinical information for early cancer diagnosis, patient prognosis, personalized therapy, and cancer progress monitoring etc. It has been proved that the disease progress is associated with an increase in mesenchymal CTCs, while...
Folic acid-conjugated organically modified silica nanoparticles for enhanced targeted delivery in cancer cells and tumor in vivo.
Yin F
Journal of Material Chemistry B: Materials for Biology and Medicine, 3(29), 6081-6093 (2015)
Yumei Wang et al.
Materials science & engineering. C, Materials for biological applications, 103, 109737-109737 (2019-07-28)
In this study, twisted rod-like chiral mesoporous silicas (CMSs) with discriminating chiral characteristics (D/L) were designed and biomimetic synthesized by using L- and d-alanine derivatives as templates, and employed as poorly water-soluble chiral drug ibuprofen (IBU) carriers. The morphology and...
Ruogu Qi et al.
Nature communications, 8(1), 2166-2166 (2017-12-20)
Advanced-stage epithelial ovarian cancers are amongst the most difficult to treat tumors and have proven to be refractory to most cytotoxic, molecularly targeted, or immunotherapeutic approaches. Here, we report that nanoparticle-drug conjugates (NDCs) of monomethyl auristatin E (MMAE) significantly increase...
J David Stack et al.
Journal of tissue engineering and regenerative medicine, 11(10), 2785-2795 (2016-05-21)
Osteochondral lesions resulting from osteochondritis dissecans are problematic to treat and present a significant challenge for clinicians. The aims of this study were to investigate the use of a scaffold-assisted microfracture approach, employing a novel, multilayered, collagen-based, osteochondral graft substitute...
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical ServiceSupport
Customer SupportContact UsFAQSafety Data Sheets (SDS)Certificates (COA/COO)Quality & RegulatoryCalculators & AppsWebinarsSocial Media
MilliporeSigma
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
Reproduction of any materials from the site is strictly forbidden without permission.